Hey buddy , can you spare a jab or two?? Pretty please?A series of welcome news! Plus immediately after complaining Alberta realized it wasn’t the US and is finally progressing with a soft lockdown.
Cherry on top is I’ve learned we’ve secured 11 full sets of vaccines per citizen in Canada (which is way beyond the US)... which makes us the greedy buyers of the world I suppose, but hopefully we’ll help distribute excess to places in need.
Hope they have a set for me as well (PR of 11 years), we will see if we get those 11 doses in any reasonable timeframe or late next year from the bargain binCherry on top is I’ve learned we’ve secured 11 full sets of vaccines per citizen in Canada (which is way beyond the US)... which makes us the greedy buyers of the world I suppose, but hopefully we’ll help distribute excess to places in need.
That is not what I said. I said Florida has been better than NY and NJ. Please go back a few posts and and read what I said about Florida's handling of the unemployment system.
A series of welcome news! Plus immediately after complaining Alberta realized it wasn’t the US and is finally progressing with a soft lockdown.
Cherry on top is I’ve learned we’ve secured 11 full sets of vaccines per citizen in Canada (which is way beyond the US)... which makes us the greedy buyers of the world I suppose, but hopefully we’ll help distribute excess to places in need.
A series of welcome news! Plus immediately after complaining Alberta realized it wasn’t the US and is finally progressing with a soft lockdown.
Cherry on top is I’ve learned we’ve secured 11 full sets of vaccines per citizen in Canada (which is way beyond the US)... which makes us the greedy buyers of the world I suppose, but hopefully we’ll help distribute excess to places in need.
I’m not worried about having it BEFORE I get on a airplane packed with strangers!I wonder what the cost will be. The NY/NJ airports namely Newark International is offering rapid testing for Covid at $200 per person before one boards their flight.
We will appeal to participants to remain in the ongoing Phase 3 study as originally randomized for as long as possible, ideally until a COVID-19 vaccine has full regulatory approval following the accumulation of 6 months of safety follow-up data after Dose 2. The study team responsible for study conduct would remain blinded to individual participant randomization until this time.
Questions yes but really does not shed more light on the "why".Interesting:
Florida’s justification for raiding COVID data whistleblower Rebekah Jones is looking a little shaky
The username, password, and email address were all freely accessible on the webwww.theverge.com
Cannot be said enough.But they’re fighters...and they had to deal with this completely of nowhere...first...with a population density that always amplifies any situation. They stayed home...they voluntarily shut their own economies down...and have gotten backstabbed/stiffed so far. They stayed up all night and did the yoeman’s medical work...all are benefiting now.
From the Pfizer-BioNTech COVID-19 Vaccine VRBPAC Briefing Document Page 15 and 16 concerning those in the study(Which a few of the forum members are): Gives expected time frame for full approval.
From the Pfizer-BioNTech COVID-19 Vaccine VRBPAC Briefing Document Page 15 and 16 concerning those in the study(Which a few of the forum members are): Gives expected time frame for full approval.
This lines up with what I had read as well earlier. The 6 months of safety data seems to be the requirement for full approval. If they got to the 2 month mark needed for EUA in November that means by some time in March they would be at 6 months and ready for full approval. Seems to lineup with the projection that healthy adults in the general population should be able to get the vaccine in April with everyone going by June.Interesting. I can totally understand why they would want people to continue with the study, but if you have the option to get the vaccine, you may want to incase you are in the placebo group.
Interesting:
Florida’s justification for raiding COVID data whistleblower Rebekah Jones is looking a little shaky
The username, password, and email address were all freely accessible on the webwww.theverge.com
For myself, I had the mild symptoms (Fever, chills, body aches etc.) on the second shot so I have high confidence that I got the vaccine, But if proof of vaccination is required to participate in events or trips that could be a temptation to exit study( I would likely opt for the good of the many and not exit). Since if you exit and had the vaccine you are good, and if you exit and had the placebo, they will unmask and you will then know. They will also vaccinate you if you qualify. So the only reason to not exit is the good of the many over the good of the one.This lines up with what I had read as well earlier. The 6 months of safety data seems to be the requirement for full approval. If they got to the 2 month mark needed for EUA in November that means by some time in March they would be at 6 months and ready for full approval. Seems to lineup with the projection that healthy adults in the general population should be able to get the vaccine in April with everyone going by June.
I think I’d want to get the vaccine sooner if I was in the trial and got the placebo but it’s only March or April so not too long to wait.
I read somewhere online that there is a possibility that all the vaccine study recipients will receive another shot, regardless of whether they got the placebo or actual vaccine. The shot would be given "blind", so that those with the vaccine would be given the placebo, and vice versa. This would vaccinate the original placebo-goers, and allow the study to continue in real time.Interesting. I can totally understand why they would want people to continue with the study, but if you have the option to get the vaccine, you may want to incase you are in the placebo group.
Wouldn’t you lose the control group then? If you vaccinate the placebo group then there is nothing to compare the vaccine group to. I think after 6 months and millions of vaccinations they probably have enough efficacy data anyway. On the safety side they will continue to track any adverse reactions of the vaccine group for 2 years just in case. We will also have hundreds of millions of people vaccinated so plenty of data.I read somewhere online that there is a possibility that all the vaccine study recipients will receive another shot, regardless of whether they got the placebo or actual vaccine. The shot would be given "blind", so that those with the vaccine would be given the placebo, and vice versa. This would vaccinate the original placebo-goers, and allow the study to continue in real time.
Register on WDWMAGIC. This sidebar will go away, and you'll see fewer ads.